• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例胰高血糖素瘤综合征病例——胰高血糖素与胰岛素的异质性

A case with glucagonoma syndrome--heterogeneity of glucagon and insulin.

作者信息

Fukushima H, Yamaguchi K, Uzawa H

出版信息

Endocrinol Jpn. 1981 Oct;28(5):575-82. doi: 10.1507/endocrj1954.28.575.

DOI:10.1507/endocrj1954.28.575
PMID:6284494
Abstract

The heterogeneity of glucagon and insulin in plasma and tissue extracts from a 57-year-old female with glucagonoma syndrome with surgically and autopsy verified islet-cell tumors was studied by Bio-Gel P-10 filtration. The preoperative plasma immunoreactive glucagon (IRG) level was 20.2 ng/ml, and plasma glucagon-like immunoreactivity(GLI) 25.8 ng/ml. The column chromatography of the preoperative plasma revealed three or four IRG components and four GLI components. Among these, peak II, the large glucagon immunoreactivity (LGI) peak, considered a candidate for proglucagon, was prominent, along with peak III. The resected metastatic liver tumor contained an enormous amount of IRG and an appreciable amount of immunoreactive insulin (IRI), indicating that the elevated plasma IRG was mainly of tumor origin. The IRG pattern of the tumor tissue extract revealed a small quantity of IRG in peaks I and II, and a large amount in peak III; control pancreatic tissue extract manifested a similar elution pattern. The IRI elution pattern of the tumor tissue extract revealed two major IRI peaks which migrated close to the elution volume of cytochrome C and insulin, respectively. This is a quite different pattern from the control pancreatic tissue extract in which the RI peak was localized in the elution volume of the insulin. We conclude that the present metastatic liver tumor produced not only enormous amounts of glucagon but heterogeneous peptides which contained immunological insulin determinants within their.

摘要

采用生物凝胶P - 10过滤法,研究了一名57岁患有胰高血糖素瘤综合征且经手术及尸检证实存在胰岛细胞瘤的女性患者血浆和组织提取物中胰高血糖素和胰岛素的异质性。术前血浆免疫反应性胰高血糖素(IRG)水平为20.2 ng/ml,血浆胰高血糖素样免疫反应性(GLI)为25.8 ng/ml。术前血浆的柱色谱分析显示有三或四种IRG成分和四种GLI成分。其中,被认为是胰高血糖素原候选物的大胰高血糖素免疫反应性(LGI)峰即峰II,与峰III一样显著。切除的转移性肝肿瘤含有大量IRG和相当数量的免疫反应性胰岛素(IRI),这表明血浆IRG升高主要源于肿瘤。肿瘤组织提取物的IRG模式显示,峰I和峰II中有少量IRG,峰III中有大量IRG;对照胰腺组织提取物表现出类似的洗脱模式。肿瘤组织提取物的IRI洗脱模式显示有两个主要的IRI峰,分别接近细胞色素C和胰岛素的洗脱体积迁移。这与对照胰腺组织提取物的模式截然不同,对照胰腺组织提取物中的IRI峰位于胰岛素的洗脱体积处。我们得出结论,目前的转移性肝肿瘤不仅产生大量胰高血糖素,还产生其内部含有免疫胰岛素决定簇的异质性肽。

相似文献

1
A case with glucagonoma syndrome--heterogeneity of glucagon and insulin.一例胰高血糖素瘤综合征病例——胰高血糖素与胰岛素的异质性
Endocrinol Jpn. 1981 Oct;28(5):575-82. doi: 10.1507/endocrj1954.28.575.
2
A case with glucagonoma syndrome--endocrine and metabolic studies.一例胰高血糖素瘤综合征病例——内分泌与代谢研究
Endocrinol Jpn. 1981 Apr;28(2):111-25. doi: 10.1507/endocrj1954.28.111.
3
Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".四例胰高血糖素瘤患者的血浆免疫反应性胰高血糖素组分:“大胰高血糖素免疫反应性”增加。
Diabetologia. 1976 Aug;12(4):319-26. doi: 10.1007/BF00420975.
4
[Inhibitory effects of somatostatin analog (SMS 201-995) on pancreatic hormones in patients with malignant islet-cell carcinoma].生长抑素类似物(SMS 201-995)对恶性胰岛细胞瘤患者胰腺激素的抑制作用
Nihon Naibunpi Gakkai Zasshi. 1988 Aug 20;64(8):666-76. doi: 10.1507/endocrine1927.64.8_666.
5
Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
Metabolism. 1984 Aug;33(8):728-33. doi: 10.1016/0026-0495(84)90213-0.
6
Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.胰腺A细胞瘤的分子与细胞分析
Cancer. 1990 Apr 15;65(8):1762-70. doi: 10.1002/1097-0142(19900415)65:8<1762::aid-cncr2820650817>3.0.co;2-q.
7
Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.一位胰高血糖素瘤患者血浆及肿瘤提取物中胰高血糖素的分泌反应和免疫化学异质性
Horm Res. 1986;23(3):159-66. doi: 10.1159/000180312.
8
Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.血浆胰高血糖素的异质性。正常受试者和慢性肾衰竭患者的循环成分。
J Clin Invest. 1976 Sep;58(3):742-50. doi: 10.1172/JCI108521.
9
Differences in molecular heterogeneity of glucagon-like immunoreactivity in plasma and liver metastases of a patient with alpha-cell tumor.一名α细胞瘤患者血浆和肝转移灶中胰高血糖素样免疫反应性的分子异质性差异。
Exp Clin Endocrinol. 1985 Feb;85(1):89-94. doi: 10.1055/s-0029-1210424.
10
Molecular forms of glucagon-like peptide-1 in human pancreas and glucagonomas.
J Clin Endocrinol Metab. 1985 Sep;61(3):472-9. doi: 10.1210/jcem-61-3-472.